ผลิตภัณฑ์กองทุนรวมและการทำหน้าที่ของตัวกลางในการเสนอขายหน่วยลงทุน (Product and Distributor Monitoring) ประกาศ ณ วันที่ 2 มีนาคม พ.ศ. 2560
objective, purpose, or strategy of operation or procurement of benefit of REIT for investor’s understanding and use it as guideline for monitoring REIT business operation direction in the future; 2.2
common control with another entity. performs analytical functions that are necessary for the issuing or monitoring of a credit rating or participates in determining credit ratings, including an employee
under its 50-year concession with the total generating capacity of 48,000 cubic meters per day. The generating capacity is divided into 2 phases; Phase 1 commenced its operation in December 2018 at 24,000
1 ( Translation ) Ref. NEP146-2017 October 25, 2017 Subject : Resolutions of the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares to investors in private placement, the acquisition of assets and convening the Extraordinary General Meeting of the Shareholders No. 1/2018 (Revise 3) To : President, The Stock Exchange of Thailand Attachment : 1. Capital Increase Report Form (F 53-4) 2. Information Memorandum in relation to the al...
13486, including relevant licenses 6,336 square meters 3 76 items of machinery and equipment for the manufacturing business, including relevant licenses - This is to improve the financial position and
spaces approximated 5,000 square meters and The New Wattnapat Samui Hospital Company Limited will purchase the land for using totally 3 plots ( สามแปลง) which located in Suratthani, all the fields are
spaces approximated 5,000 square meters and The New Wattnapat Samui Hospital Company Limited will purchase the land for using totally 3 plots ( สามแปลง) which located in Suratthani, all the fields are
and total usable floor area of 9,000 square meters, on 6-3-5.4 Rai plots of Land. This expansion of Wattanapat Samui Hospital causing the Company to comply with the disclosure requirement, entitled
issuance of improper auditor’s reports, as well as countermeasures for mitigating such risks. 4.1 Inspection results on the quality control system by the Audit Firm (internal monitoring) (1) Name of